![Barrie Wilkinson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barrie Wilkinson
Fondatore presso Isomerase Therapeutics Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Robert Booth | M | - |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB.
Isomerase Therapeutics Ltd.
![]() Isomerase Therapeutics Ltd. BiotechnologyHealth Technology Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom. | - |
Matthew Gregory | M | - |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB.
Isomerase Therapeutics Ltd.
![]() Isomerase Therapeutics Ltd. BiotechnologyHealth Technology Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom. | 21 anni |
Steven Moss | M | - |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB.
Isomerase Therapeutics Ltd.
![]() Isomerase Therapeutics Ltd. BiotechnologyHealth Technology Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom. | 22 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Peter F. Leadlay | M | - |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | 17 anni |
Sue Scammell | F | - |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | - |
Abebe Dinku Belay | M | 64 |
University of Leeds
| 5 anni |
Edward Hodgkin | M | 61 |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | 6 anni |
Jack Clarke | M | 59 |
University of Leeds
| 6 anni |
Peter Finan | M | 57 |
University of Leeds
| 7 anni |
Mike Mitchell | M | - |
University of Leeds
| 8 anni |
Marc Robert Schneidman | M | - |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | - |
Raymond Wolfson | M | 69 |
University of Leeds
| - |
Phil Harrison | M | - |
University of Leeds
| 4 anni |
Steve Howell | M | - |
University of Leeds
| 3 anni |
Tony Morrison | M | - |
University of Leeds
| 4 anni |
Hang Tat Yau | M | 55 |
University of Leeds
| 1 anni |
Wai Shun Ko | M | 54 |
University of Leeds
| 3 anni |
Fui Kiang Liew | M | 57 |
University of Leeds
| 3 anni |
Pin Yen Ma | F | 50 |
University of Leeds
| 3 anni |
Peter S. Ringrose | M | 78 |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | 8 anni |
Man Wai Li | M | 55 |
University of Leeds
| 4 anni |
John Mesrie | M | - |
University of Leeds
| 3 anni |
Simon Carrier | M | - |
University of Leeds
| 3 anni |
Richard Thompson | M | - |
University of Leeds
| 4 anni |
Christopher Michael Leslie | M | 52 |
University of Leeds
| 4 anni |
Manaf bin Haji Metussin | M | - |
University of Leeds
| 4 anni |
Rachel Lord | F | 58 |
University of Leeds
| 4 anni |
Liam Devlin | M | - |
University of Leeds
| 4 anni |
Miguel Veiga Pestana | M | - |
University of Leeds
| 4 anni |
Andrew Myers | M | - |
University of Leeds
| 3 anni |
Mark McDonald | M | 51 |
University of Leeds
| 4 anni |
Mark Pattenden | M | - |
University of Leeds
| 3 anni |
Warren Taylor | M | - |
University of Leeds
| 3 anni |
Stephen Lam | M | 57 |
University of Leeds
| 4 anni |
Yi Wei Zhang | M | 68 |
University of Leeds
| 3 anni |
Aristides Kamvysis | M | - |
University of Leeds
| 4 anni |
Mark Canning | M | - |
University of Leeds
| 3 anni |
Siti Hamisah binti Tapsir | M | 63 |
University of Leeds
| 3 anni |
Anthony Hamilton | M | - |
University of Leeds
| 3 anni |
David Wilson | M | - |
University of Leeds
| 3 anni |
Ian Sharp | M | - |
University of Leeds
| 3 anni |
Shalom Patterson | M | - |
University of Leeds
| 3 anni |
Matt Boss | M | - |
University of Leeds
| 4 anni |
Mark Charkin | M | - |
University of Leeds
| 4 anni |
Nisha Malhotra | F | 77 |
University of Leeds
| 2 anni |
Simon Winter | M | 48 |
University of Leeds
| 4 anni |
Stephen Kennett Miller | M | 67 |
University of Leeds
| 1 anni |
Zhi Feng Long | M | 62 |
University of Leeds
| 3 anni |
Jon Miller | M | - |
University of Leeds
| 4 anni |
Dominic Chong Yu | M | 52 |
University of Leeds
| 4 anni |
Sai Cheong Tham | M | 55 |
University of Leeds
| 4 anni |
Jonathan Mogg | M | - |
University of Leeds
| 4 anni |
Paul Sansbury | M | - |
University of Leeds
| 4 anni |
Siew Moh Wong | M | 49 |
University of Leeds
| 4 anni |
David Gerald Smith | M | 56 |
University of Leeds
| 4 anni |
James Benfield | M | 50 |
University of Leeds
| 3 anni |
Jonathan Cannon | M | - |
University of Leeds
| 4 anni |
Robert James Horrocks | M | - |
University of Leeds
| 8 anni |
Dereck Tait | M | - |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | - |
Kim Seng Teh | M | 57 |
University of Leeds
| 3 anni |
Michael Joyce | M | 55 |
University of Leeds
| 4 anni |
Martin Forbes | M | - |
University of Leeds
| 4 anni |
Nick McKeown | M | - |
University of Leeds
| 4 anni |
Matt Perkins | M | - |
University of Leeds
| 4 anni |
Vivien Pell | F | - |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | - |
David Holdcroft | M | - |
University of Leeds
| 5 anni |
Ming-Qiang Zhang | M | - |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | - |
Mark W. Bodmer | M | 69 |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | - |
Stuart John Rowley | M | 56 |
University of Leeds
| 4 anni |
Amadou Kassim Mansaray | M | - |
University of Leeds
| 1 anni |
Phillip James Boyd | M | 61 |
University of Leeds
| 1 anni |
Alyson Greenwood | F | - |
University of Leeds
| 4 anni |
Mark Nathan Lampert | M | 56 |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | - |
Alan J. Lewis | M | 78 |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | - |
Raj Shant | M | 55 |
University of Leeds
| 3 anni |
Adin Seskin | M | - |
University of Leeds
| 1 anni |
Sean W. Lanigan | M | - |
University of Leeds
| 3 anni |
Mostaque Siddiqui | M | 71 |
University of Leeds
| 1 anni |
Chong Guang Wang | M | 58 |
University of Leeds
| 4 anni |
Roman Nikolayevich Sulzhik | M | 50 |
University of Leeds
| 4 anni |
Ashley Gerard Cooper | M | 58 |
University of Leeds
| 4 anni |
Sarah Jones | F | - |
University of Leeds
| 2 anni |
Elina Mohamed | F | 53 |
University of Leeds
| 3 anni |
John Edge | M | - |
University of Leeds
| 4 anni |
King Pui Szeto | M | 69 |
University of Leeds
| 3 anni |
Joanne Joynson-Hewlett | F | - |
University of Leeds
| - |
Haytham Hilmi Mohammed Fodah | M | 57 |
University of Leeds
| 1 anni |
Ian Waterfield | M | - |
University of Leeds
| 3 anni |
Kevin Vyse-Peacock | M | 57 |
University of Leeds
| 2 anni |
Melanie McCullagh | M | - |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | 5 anni |
Duncan Edward Ford | M | 56 |
University of Leeds
| 4 anni |
Ahmad Ruhaizad Hashim | M | 56 |
University of Leeds
| 4 anni |
Christine Martin | M | - |
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | 18 anni |
David Leatherbarrow | M | 55 |
University of Leeds
| 4 anni |
Oliver Charles Hughes | M | 54 |
University of Leeds
| 1 anni |
Mark McDonald | M | - |
University of Leeds
| 4 anni |
Nigel Sperring | M | - |
University of Leeds
| 4 anni |
Ederyn Williams | M | 78 |
University of Leeds
| - |
Raymond Barlow | M | 55 |
University of Leeds
| 5 anni |
Norashikin Muhamad | F | - |
University of Leeds
| 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Regno Unito | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Barrie Wilkinson
- Contatti personali